Search Results - Masaaki Hashiguchi

Lysosomal degradation of PD-L1 is associated with immune-related adverse events during anti-PD-L1 immunotherapy in NSCLC patients by Takeru Kashiwada, Ryotaro Takano, Ryotaro Takano, Fumihiko Ando, Fumihiko Ando, Shoko Kuroda, Yoshishige Miyabe, Yoshishige Miyabe, Ryuji Owada, Akihiko Miyanaga, Tomoko Asatsuma-Okumura, Masaaki Hashiguchi, Yoshikazu Kanazawa, Hiroshi Yoshida, Masahiro Seike, Akihiko Gemma, Yoshiko Iwai

Connect to this object online.

Combination of plasma MMPs and PD-1-binding soluble PD-L1 predicts recurrence in gastric cancer and the efficacy of immune checkpoint inhibitors in non-small cell lung cancer by Fumihiko Ando, Fumihiko Ando, Takeru Kashiwada, Shoko Kuroda, Takenori Fujii, Ryotaro Takano, Ryotaro Takano, Yoshishige Miyabe, Yoshishige Miyabe, Shinobu Kunugi, Takashi Sakatani, Akihiko Miyanaga, Tomoko Asatsuma-Okumura, Masaaki Hashiguchi, Yoshikazu Kanazawa, Ryuji Ohashi, Hiroshi Yoshida, Masahiro Seike, Akihiko Gemma, Yoshiko Iwai

Connect to this object online.